Two New FOP Treatments Are Here. Make Sure Our Community Knows About Them.

In five weeks, the FDA approved Regeneron's Pasatru and Mirum's Atebrioz for fibrodysplasia ossificans progressiva, a rare disease that slowly turns muscle and tendons into bone. Here is what Black patients and families should know.